CHRISTINA KOZLOVSKI: Open Payments
NPI 1992168603 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$119 in 6 payments from 5 companies in 2025. Trend: 2023 $134 · 2024 $75 · 2025 $119
Food & beverage: $119
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $46 |
| PFIZER INC. | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| Lilly USA, LLC | 1 | $18 |
| Astellas Pharma US Inc | 1 | $16 |
Products named: Ozempic, PREVNAR 20, AIRSUPRA, MOUNJARO, Veozah.
Industry payments across MO — which companies pay providers there.
